Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Organogenesis ORG -- Ignore unavailable to you. Want to Upgrade?

To: CMason who wrote (1203)	2/16/2000 6:15:00 PM
From: Bruce Cullen	Read Replies (2) \| Respond to of 1223

Sounds like inside Information? Is it? I disagree with your points, no harm intended. Bruce Cullen SherwoodCoastsGroup.com

To: CMason who wrote (1203)	3/4/2000 12:11:00 PM
From: jelrod3	Read Replies (1) \| Respond to of 1223

Good post. My calculations show that ORG is selling only about 225 "pecker patches" per month, assuming $975 a pop for each patch. Clearly, the lack of Medicare coverage is suppressing sales big time. Not much said about the pipeline for this company, except that their liver machine may be years and years away. Do you know if they have any real angles or scientists working on emerging concepts, like growing organs from cloned cells, etc? The shorts will clobber them once the biotech mania cools off...as it always does.